@article{d1344b945b194934abe62c8c0e49ec2b,
title = "Response to: Comment on Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: The RRRR study, a randomised controlled trial' by Tanaka et al ' by Berkhout et al",
keywords = "DMARDs (biological), rheumatoid arthritis, treatment",
author = "Yoshiya Tanaka and Koji Oba and Tsutomu Takeuchi",
year = "2021",
month = nov,
day = "1",
doi = "10.1136/annrheumdis-2019-216593",
language = "English",
volume = "80",
pages = "E173",
journal = "Annals of the rheumatic diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "11",
}